Stemnovate

Exclusive Offer: Get 30% off on all primary cells, iPSC lines and iPS-Hepatocytes in Q2-2021. See Product for details

Stemnovate is ISO 9001:2015 certified company

DRUG DISCOVERY PLATFORM
All ethnicities included
Genotyping – drug metabolising enzymes
Reducing Animal Testing
Order now
Multicellular modelling – NASH, Cirrhosis & liver cancers
Cytochrome P450 Profiling
Next-gen patented chip technology
Order now
STEMNOVATE DIGI HEALTH™
HEALTH PASSPORT COVID & BEYOND
COMING SOON
Order now
BIOBANK OF INDUCED PLURIPOTENT STEM CELLS
UNIQUE FEMALE AND MALE LINES
DIFFERENTIATION- LIVER, HEART, BRAIN, IMMUNE SYSTEM
BIOINFORMATICS

Order now

ABOUT US

Our pioneering platform for targeted drug development is truly unique. In every sense. We account for individual variations in patients’ genetics, physiology and health. Enabling the most precise, carefully targeted drug development from the earliest stages of the process. Delivering a safer, more cost-effective and best drug discovery for the human race. Preventing the needless loss of countless animal lives in a process that up until now has failed to predict accurate human responses. Stemnovate have best human and animal cell tools to advance medical research and drug discovery.

Products

Induced Pluripotent stem cell lines

Human & Multispecies Primary cells

Cell culture & analysis package

Services

Cell Reprogramming

Cell Differentiation

Application Development

Data

Pharmacogenomic Data

Single Nucleotide Polymorphism

Transcriptomics

Pharmacokinetic/Pharmacodynamic Data

Device

Microphysiological systems

Microfluidic design, prototyping and manufacturing

Biosensing and Automation

HOW IT WORKS

Set Up Account

Head over to the sign-up page and fill in your company details.

Browse products

Once signed up, you can browse our full product and service list.

Security Check

We’ll carry out a standard security check to ensure everything is in order.

Make Purchase

Add your choices to the shopping basket. Make a purchase online or by invoice.

LIVER ON A CHIP
According to FDA, Drug-Induced Liver Injury has been the most frequent single cause of safety-related drug marketing withdrawals for the past 50 years and is often associated with acute liver failures. DILI studies have shown latency to...Read more
INVESTING IN SMART SYSTEMS
Stemnovate’s Liver on chip project is co funded by Innovate UK, the million pound project is aimed at advancing the microfluidic and biosensor technology that will improve drug testing and help patients by increasing efficacy and effectiveness. The new stem cell technique negates the need for testing in animals or humans and could prove a personalised medicine gamechanger.Read more
SUPPORTING VETERINARY RESEARCH
According to Public Health England in 2012, over 4 million procedures were conducted on animals in the United Kingdom with 99% animal research involved mice, hamsters, guinea pigs, ferrets, rabbits, rats and turkeys with less than... Read more